Cooperative Agreement NU2HGH000111

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $42,680,510 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to the Shwari Health Association, a non-profit organization in Cameroon. The 5-year award, which commenced on September 30, 2024, will support the SAFECARE-CAMEROON project to develop, implement, and sustain comprehensive facility and community-based HIV services for children, adolescents, and adults in Cameroon. Key objectives include enhancing the...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS Program (CFDA 93.067) provides $13,703,623 to the Cameroon Baptist Convention Health Board (CBCHB) from October 2024 through September 2029. The funding supports the development, implementation, and sustainment of high-quality comprehensive facility and community-based HIV 95-95-95 cascade activities for children, adolescents, and adults in Cameroon under the President's Emergency...

The Centers for Disease Control and Prevention (CDC) awarded a $15,221,142 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to the Association Camerounaise Pour LE Marketing Social (ACMS) in Cameroon. The five-year award, beginning September 30, 2024, aims to develop, implement, and sustain high-quality comprehensive facility and community-based HIV 95-95-95 cascade activities for children, adolescents, and adults in Cameroon under the President's Emergency Plan for AIDS...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $21,735,374 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) to develop, implement, and sustain high-quality comprehensive facility and community-based HIV activities in Cameroon. This 5-year award, effective from September 30, 2024 to September 29, 2029, will support EGPAF's efforts to combat the HIV/AIDS epidemic in Cameroon through prevention, care,...

This federal Cooperative Agreement award, provided by the U.S. Department of Health and Human Services' Centers for Disease Control and Prevention under the Global AIDS program (CFDA 93.067), will support the Cameroon Baptist Convention Health Board to develop, implement, and sustain high-quality comprehensive HIV cascade activities for children, adolescents, and adults in facility and community-based settings in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR). The...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) provides $4,838,896 to the Cameroon Baptist Convention Health Board (CBCHB) to develop, implement, and sustain high-quality comprehensive facility and community-based HIV 95-95-95 cascade activities for children, adolescents, and adults in Cameroon. The award supports a range of technical assistance, service delivery, and capacity-building activities aimed at...

This Cooperative Agreement award, provided by the U.S. Department of State's Bureau of African Affairs under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program (CFDA 19.029), aims to enhance HIV service delivery and outcomes for key populations in Cameroon. The $250,000 award, effective from September 30, 2024, to September 30, 2026, will be implemented by Health Development Consultancy Services (Hedecs), a foundation based in Cameroon. The award supports data-driven...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $6,960,000 Cooperative Agreement under the Global AIDS (CFDA 93.067) federal grant program to the Crihss Foundation in Cameroon. The 5-year "Integrated Transformational and Sustainable Sample Transport (INTRASSAT)" project, which began on September 30, 2024, aims to establish an integrated and sustainable sample transport system in Cameroon. The project objectives are to streamline fragmented diagnostic sample referral...

This federal Cooperative Agreement award is from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067). The $5,023,124 award to the National Tuberculosis Control Program in Cameroon will support comprehensive efforts to combat HIV/AIDS globally through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). The award funds a range of technical assistance, service delivery, and capacity-building activities aimed at preventing new HIV infections,...

Metabiota, Inc. was awarded a $3.5 million cooperative agreement from the Defense Health Agency under the Department of Defense HIV/AIDS Prevention Program (CFDA 12.350) for the period of October 1, 2021 through September 30, 2023. The award will support Metabiota's efforts to build HIV epidemic control in Cameroon through strengthening HIV prevention, testing, linkage to care and treatment, and viral suppression programs within the Cameroon Defense Force. As part of this cooperative...